Effect of Mepolizumab in OCS Dependent Severe Eosinophilic Asthma Patients with History of Omalizumab Treatment

被引：0
|
作者：
Prazma, Charlene M. [1 ]
Magnan, Antoine [2 ]
Price, Robert [3 ]
Ortega, Hector [1 ]
Yancey, Steven W. [1 ]
Albers, Frank C. [1 ]
机构：
[1] GlaxoSmithKline, Res Triangle Pk, NC USA
[2] Univ Nantes, Nantes, France
[3] GlaxoSmithKline, Stockley Pk, England
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2015年 / 135卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2014.12.1879
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
L6
引用
收藏
页码：AB383 / AB383
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma
    Agache, Ioana
    Beltran, Jessica
    Akdis, Cezmi
    Akdis, Mubeccel
    Canelo-Aybar, Carlos
    Canonica, Giorgio Walter
    Casale, Thomas
    Chivato, Tomas
    Corren, Jonathan
    Del Giacco, Stefano
    Eiwegger, Thomas
    Firinu, Davide
    Gern, James E.
    Hamelmann, Eckard
    Hanania, Nicola
    Makela, Mika
    Martin, Irene Hernandez
    Nair, Parameswaran
    O'Mahony, Liam
    Papadopoulos, Nikolaos G.
    Papi, Alberto
    Park, Hae-Sim
    Perez de Llano, Luis
    Posso, Margarita
    Rocha, Claudio
    Quirce, Santiago
    Sastre, Joaquin
    Shamji, Mohamed
    Song, Yang
    Steiner, Corinna
    Schwarze, Jurgen
    Alonso-Coello, Pablo
    Palomares, Oscar
    Jutel, Marek
    ALLERGY, 2020, 75 (05) : 1023 - 1042
  • [22] Therapeutic switch from omalizumab to mepolizumab in patients with uncontrolled severe eosinophilic asthma: Responder analysis
    Albers, F. C.
    Galkin, D.
    Mavropoulou, E.
    Chapman, K. R.
    Munoz, X.
    Devouassoux, G.
    Liu, M. C.
    Chipps, B.
    Bergna, M.
    ALLERGY, 2019, 74 : 362 - 362
  • [23] Therapeutic switch from omalizumab to mepolizumab in patients with uncontrolled severe eosinophilic asthma-treatment effect by baseline blood eosinophil levels
    Albers, F. C.
    Liu, M. C.
    Chipps, B.
    Chapman, K. R.
    Munoz, X.
    Bergna, M.
    Devouassoux, G.
    Azmi, J.
    Mouneimne, D.
    Price, R.
    Galkin, D.
    ALLERGY, 2018, 73 : 348 - 348
  • [24] THE EFFECT OF MEPOLIZUMAB TREATMENT IN PATIENTS WITH SEVERE ASTHMA
    Sandhu, Yuuki
    Harada, Norihiro
    Matsuno, Kei
    Harada, Sonoko
    Sasano, Hitoshi
    Tanabe, Yuki
    Nakamura, Ai
    Takeshige, Tomohito
    Ishimori, Ayako
    Katsura, Yoko
    Makino, Fumihiko
    Ito, Jun
    Atsuta, Ryo
    Akiba, Hisaya
    Takahashi, Kazuhisa
    RESPIROLOGY, 2017, 22 : 98 - 99
  • [25] Severe eosinophilic asthma and mepolizumab
    Walsh, Garry M.
    LANCET RESPIRATORY MEDICINE, 2016, 4 (07): : 528 - 529
  • [26] MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA
    Shahzad, Q.
    Zaheer, M.
    CHEST, 2020, 157 (06) : 275A - 275A
  • [27] THE VALUE OF ORAL PREDNISOLONE IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA ON MEPOLIZUMAB TREATMENT
    Yang, J. F.
    Busby, J.
    Heaney, L. G.
    Brightling, C. E.
    Pavord, I. D.
    Borg, K.
    McDowell, P. J.
    Diver, S.
    Shrimanker, R.
    Smith, S. J.
    Shepherd, M.
    Lee, W. N.
    Chaudhuri, R.
    THORAX, 2021, 76 : A141 - A141
  • [28] Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes
    Prazma, Charlene M.
    Idzko, Marco
    Douglass, Jo Anne
    Bourdin, Arnaud
    Mallett, Stephen
    Albers, Frank C.
    Yancey, Steven W.
    JOURNAL OF ASTHMA AND ALLERGY, 2021, 14 : 675 - 683
  • [29] The impact of treatment with omalizumab, mepolizumab, benralizumab, dupilumab and tezepelumab in patients with severe asthma
    Mochizuki, Taichi
    Inoue, Yasushi
    Ueda, Ryuta
    Nagase, Seisuke
    Kuwano, Kazuyoshi
    Umeda, Akira
    To, Yasuo
    RESPIROLOGY, 2023, 28 : 339 - 340
  • [30] Mepolizumab for severe eosinophilic asthma
    Robinson, Douglas S.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2013, 7 (01) : 13 - 17
12345